The average rate of embryos carrying partial abnormalities is just over a 10%, which is a noticeable risk and could lead to failure of implantation rate, increase of pregnancy loss, or even an affected child.
BACKGROUND: The transfer of multiple embryos in cycles of in vitro fertilization is associated with multiple pregnancy and numerous increased maternal and fetal risks. The primary means for controlling these risks is to transfer a single embryo. There has been gradually increasing use of elective single embryo transfer (eSET) among fertility centers in the United States. In 2013, the Centers for Disease Control and Prevention (CDC) reported that 21.4% of fresh embryo transfers in patients <35 years old employed eSET, and increase from 12.2% in 2011. However, in 2013 the proportion of eSET cycles at each center varied from 0.0% to 96.9%. The factors associated with each center's usage of eSET may have scientific and policy implications.
OBJECTIVE: To determine which clinic parameters are associated with the proportion of fresh embryo transfers using eSET and the rate of multiple pregnancy at fertility centers in the United States.
DESIGN: Analysis of national registry data published on the CDC website.
MATERIALS AND METHODS: The national results published by the CDC for reporting year 2012 were used to develop the model. Results for reporting year 2013 were analyzed separately to see if a similar model would result. The unit of analysis was each reporting center. Analysis of covariance models were developed with forward stepwise selection to identify factors that predict frequency of eSET in fresh non-donor cycles and the multiple pregnancy rate in patients <35 years of age at reporting centers. Potential predictors of eSET frequency included the reporting center's implantation rate with fresh embryos in that age group, implantation rate with thawed embryos in that age group, SART membership, clinic location in an insurance-mandated state, total clinic cycle volume, and the reported proportion of cycles using genetic screening. Potential predictors of multiple pregnancy rate in fresh transfers (age<35 years) included eSET rate, implantation rate of fresh embryos (age<35 years), average number of fresh embryos transferred, implantation rate of thawed embryos (age<35 years), total cycle volume, and proportion of cycles using genetic screening.
RESULTS: For 2012, the significant predictors of eSET use were (in order of statistical significance) total clinical cycle volume (P<0.0001), the implantation rate with thawed embryos (P¼0.0021), SART membership (P¼0.0059), and implantation rate with fresh embryos (P¼0.0154), all of which were positive correlations. For 2013, the significant predictors of eSET use were the implantation rate with thawed embryos (P<0.0001), total clinic cycle volume (P¼0.0001), and the implantation rate with fresh embryos (P¼0.0225). For 2012, significant predictors of each center's multiple pregnancy rate in fresh cycles included eSET frequency (P<0.0001, negative correlation) and the implantation rate with fresh embryos (P<0.0001, positive correlation). Analysis of the 2013 data set found the same significant predictors.
CONCLUSIONS: The results of the separate analyses of reporting years 2012 and 2013 were very similar. Centers with the greatest proportion of eSET use in fresh transfers in young patients were those with greater cycle volume, high implantation rates with thawed embryos, SART membership (in 2012), and high implantation rates with fresh embryos. Surprisingly, the proportion of cycles employing genetic screening and location in an insurance-mandated state were not significant predictors of eSET usage. The importance of the implantation rates with thawed and fresh embryos suggests that greater success rates, particularly with thawed embryos, reduce the incentive to transfer multiple fresh embryos. The multiple pregnancy rate decreased with increasing eSET use and increased with increasing fresh transfer implantation rate, suggesting centers with greater implantation rates should further increase their eSET use.
SUPPORT: None. BACKGROUND: Oocyte cryopreservation (OC) is an important option that allows women to maintain reproductive autonomy. As the demand for OC increases, it isIt is increasingly evident that most women prefer to cryopreserve oocytes rather than embryos. Traditionally, pregnancy rates were believed to be higher with frozen cryopreserved embryos than frozen cryopreserved eggsoocytes. However, data comparing Early studies demonstrated lower clinical pregnancy and live birth rates from frozen oocytes compared to fresh oocytes. However to our knowledge, there have been no direct comparisons of outcomes between frozen cryopreserved embryos and embryos derived from frozen cryopreserved oocytes are lacking. Additionally, most studies focus on outcomes from oocyte donors, but there are very limited data on the outcomes in women undergoing autologous OC, particularly in the advanced reproductive age group.
OBJECTIVE: To We aimed to compare pregnancy outcomes in patients who underwent transfers with embryos derived from cryopreserved autologous oocytes (FOET) to to patients who underwent autologous frozen cryopreserved embryo transfers (FET). FERTILITY & STERILITY Ò e21 MATERIALS AND METHODS: We retrospectively reviewed in vitro fertilization cycles in 264 320 patients undergoing in vitro fertilization (IVF) at an academic fertility center. We included all all autologous FOET cycles (n¼57) and all frozen embryo transferFET cycles (n¼272) between 2012-2014. Fresh IVF, oocyte donor cycles and blastocyst transfers were excluded. Patient demographics and cycle characteristics were abstracted from chartscollected. Outcomes were compared between FOET and FET groups using T-test, chi-square analysis, and multivariable logistic and linear regression to adjust for age at the time of cryopreservation.
RESULT(S): 264 patients and 264 patients and 329 cycles were included in our analysis. Patients in the FOET group were younger at the time of their oocyte oocyte retrieval compared to FET patients (33.1 vs 36.4 years, p< .00132.8 vs 36.4 years, p<0.001). There were no significant differences in demographics, ovarian reserve markers, or cycle stimulation parameters. Mean survival of thawed oocytes was lower than that of thawed embryos (76.8+2.23 versus 94.3+0.76, p < .001), even when stratified by cryopreservation method (p < .001). When controlling for age, regression analysis showed no differences in implantation, clinical pregnancy rate (CPR), and live birth rates (LBR), or obstetrical outcomes between the FOET and FET groups (Table 1) . When the analysis was limited to women > 38, there were no differences in clinical pregnan-cyCPR or live birth ratesLBR between FOET and FET groups ( Table 2 ). In the FOET group, the oldest age at the time of cryopreservation to result in a live birth was 41 years old. CONCLUSION(S): OC achieves live birth rates that are comparable to embryo cryopreservation, and is a viable option even for women of advanced reproductive ages. Our findings suggest that women considering fertility preservation can be counseled that OC is as effective as embryo cryopreservation.
SUPPORT: None. References: BACKGROUND: Aneuploidy is a major contributor to decreased reproductive potential and is more prevalent with increasing age. Additionally, there is a surprisingly high occurrence of aneuploidy in infertile patients at very young ages (1). Donor oocytes are commonly used as a therapeutic option for older women. However, observed aneuploidy in very young IVF patients suggests young patients may also be prone to higher rates of aneuploidy. A large comparison of aneuploidy rates in infertile patients and oocyte donors utilizing a 24 chromosome aneuploidy platform has not been done.
OBJECTIVE: To determine the rate of aneuploidy in the donor population compared with the general IVF population.
MATERIALS AND METHODS: Patients from a single institution who underwent donor oocyte cycles with comprehensive chromosome screening (CCS) from 2009 through 2014 were included. Oocyte donors underwent routine ovarian stimulation and oocyte retrieval. After extended culture and trophectoderm biopsy, CCS was performed utilizing a validated platform. Chi-squared was utilized to compare aneuploidy rates between age matched donors and a large reference infertility population which excluded donors.
RESULTS: 169 women met inclusion criteria. Average age of donors was 26 (range 22-31), and average number of blastocysts analyzed was 8.7 (range 1-32). The rate of aneuploidy overall is significantly higher in the general IVF population compared to the donor population, 26.6% compared to 19.2% (p<0.0001). When looking specifically at women younger than 26, the rate of aneuploidy in the general IVF population is 34% compared with 18.5% in the donor population (p<0.0001). Above age 27, there is no clear difference seen (Figure 1) . CONCLUSION: The rate of aneuploidy is higher in the infertile IVF population when compared to the donor population at young ages. However, it is notable that the prevalence of aneuploidy in the donor population was still approximately 20%. While donor oocyte does provide a lower rate of aneuploidy than in the infertile population, the risk is not completely avoided and preimplantation genetic screening still provides a meaningful method of embryo selection.
FINANCIAL SUPPORT: None BACKGROUND: Vitrification has become the preferred cryopreservation method for human eggs and embryos (Vajta, 2015) . Most approaches utilize direct ''open'' exposure to liquid nitrogen (LN2) to achieve maximal cooling rates. However, closed systems are safer from theoretically toxic effects from exposure to LN2 (Bielanski and Vajta , 2009; Vajta 2015) .
A new ''closed'' vitrification system is the ''Cryotop SC'' (Kitazato Corp., Shizuoka, Japan). Cryotops are cooled within a plastic containment straw without direct LN2 contact. 
